中文 | English
Return
Total: 160 , 1/16
Show Home Prev Next End page: GO
Author:( Yunfeng WU)

1.Application of clinical pathway in urology clinical teaching to urological postgraduate students

Yunfeng HE ; Xiaohou WU

Chinese Journal of Medical Education Research 2012;11(1):74-76

2.Analysis of relationship between plasma TNF-α,IL-6 levels and brain edema caused by hypertensive intracerebral hemorrhage

Zhihao HUANG ; Yunfeng CHEN ; Xiaohong WU

Chinese Journal of Primary Medicine and Pharmacy 2012;19(11):1607-1609

3.In vitro culture and cell cycle detection of the adult degenerated nucleus pulposus

Yunfeng QIU ; Xiaotao WU ; Ziru ZHAO

Orthopedic Journal of China 2006;0(01):-

4.Principles in clinical research

Xueling WU ; Yunfeng ZHAO ; Guisheng QIAN

Chinese Journal of Medical Education Research 2003;0(04):-

5.Advances on National Surgical Adjuvant Breast and Bowel Project colorectal cancer trials

Qiuji WU ; Fuxiang ZHOU ; Yunfeng ZHOU

Journal of International Oncology 2011;38(12):930-933

6.Clinical significance of the detection of serum iNOS and SOD in patients with chronic hepatitis B

Yunfeng SHEN ; Hongbo ZHANG ; Yao WU

International Journal of Laboratory Medicine 2014;(22):3055-3056,3058

7.P-selectin and Platelet activating factor in acute patients with deep venous thrombosis

Jiang WU ; Xiaoyan LENG ; Yunfeng SONG

International Journal of Surgery 2010;37(10):659-661

8.Ubiquitin and its role in the tumor

Xiaojia GAO ; Hui YANG ; Lin WU ; Fuxiang ZHOU ; Yunfeng ZHOU

Journal of International Oncology 2015;(3):188-191

9.Effects of sodium nitroprusside (SNP) on TLR4 in U937 induced by LPS

Xueling WU ; Yunfeng ZHAO ; Xingsheng WANG ; Guisheng QIAN

Chinese Journal of Immunology 2000;0(08):-

10.Expression and significance of peripheral CXCL9 and CXCR3 in rats with acute renal allografts rejection

Jiabing LI ; Yunfeng HE ; Kang XIA ; Xiaohou WU

Journal of Third Military Medical University 2003;0(09):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 160 , 1/16 Show Home Prev Next End page: GO